Ron S. Gejman
Columbia University Irving Medical Center(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures(2016)1,028 cited
- → Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells(2016)175 cited
- → Rejection of immunogenic tumor clones is limited by clonal fraction(2018)131 cited
- → A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens(2017)92 cited
- → Opportunities and challenges for TCR mimic antibodies in cancer therapy(2016)57 cited
- → T cell receptor mimic antibodies for cancer therapy(2015)42 cited
- → Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform(2020)40 cited
- → Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures(2017)17 cited
- → The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression(2015)16 cited